i3 Consult wishes to announce the arrival of a new product in the clinical trial service space by iClinical called Minerva, a Chatbot for pharmaceutical companies and patient engagement. The Minerva chatbot offers a new modality of communication in clinical trials, by providing physicians and patients with relevant information when needed as well as providing the sponsor with trial related information. These are some of the functions the chatbot will do;
To read more about the Minerva Chatbot, click on the links below to download the documentation;
Minerva chatbot for patient engagement
For further details please and to request a private demonstration kindly contact Sridhar Byrappa PhD, CEO of iClinical as in the contact details provided:
Sridhar Byrappa PhD
CEO, iClinical Inc
Phone : 415-996-6860
Email: sridhar@iclinical.co
Website: http://iclinical.co/
LinkedIn: https://www.linkedin.com/in/sridharbyrappa/